Harmony Biosciences Holdings (HRMY) Assets Average (2020 - 2026)

Harmony Biosciences Holdings' Assets Average history runs 7 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Assets Average rose 23.79% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 23.79% YoY), while the FY2025 annual figure was $1.1 billion, up 25.42% from the prior year.
• Assets Average came in at $1.3 billion for Q1 2026 at Harmony Biosciences Holdings, up from $1.2 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $1.3 billion in Q1 2026 to a low of $448.7 million in Q1 2022.
• A 5-year average of $851.7 million and a median of $829.2 million in 2024 frame the typical range for Assets Average.
• Across the five-year window, Assets Average jumped 59.77% in 2022 and increased 15.6% in 2024, its largest moves.
• Harmony Biosciences Holdings' Assets Average stood at $658.7 million in 2022, then climbed by 20.64% to $794.6 million in 2023, then gained by 21.28% to $963.7 million in 2024, then climbed by 28.67% to $1.2 billion in 2025, then grew by 2.56% to $1.3 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $1.3 billion, $1.2 billion, and $1.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison